Related Experiment Video
Updated: Jun 4, 2026

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis
Published on: September 11, 2019
Controlled HIV viral replication, not liver disease severity associated with low bone mineral density in HIV/HCV
Diala El-Maouche1, Shruti H Mehta, Catherine Sutcliffe
1Johns Hopkins School of Medicine, Baltimore, MD, USA.
Insights
Osteoporosis is common in HIV/HCV co-infected individuals, especially African Americans. Controlled human immunodeficiency virus (HIV) replication is linked to lower bone mineral density (BMD), not liver disease severity.
Area of Science:
- Bone metabolism and osteoporosis research
- Infectious disease epidemiology
- HIV/Hepatitis C co-infection studies
Background:
- Low bone mineral density (BMD) and osteoporosis are significant health concerns.
- Co-infection with human immunodeficiency virus (HIV) and Hepatitis C virus (HCV) presents unique challenges.
- Understanding risk factors for low BMD in this population is crucial for clinical management.
Purpose of the Study:
- To determine the prevalence of low bone mineral density (BMD) in individuals with HIV/HCV co-infection.
- To identify risk factors associated with low BMD in this cohort.
- To explore the relationship between liver disease severity, HIV replication, and BMD.
Main Methods:
- A prospective cohort study of 179 HIV/HCV co-infected participants.
- Dual-energy X-ray absorptiometry (DXA) was used to assess bone mineral density (BMD).
- Liver fibrosis staging via METAVIR system and assessment of HIV RNA levels were correlated with BMD (Z-scores).
Main Results:
- The prevalence of osteoporosis was 28%, with 25% affected at the lumbar spine.
- Lower Z-scores, indicating lower bone mineral density (BMD), were significantly associated with controlled HIV replication (HIV RNA <400 copies/ml).
- No association was found between the severity of liver fibrosis and BMD.
Conclusions:
- Osteoporosis is highly prevalent in HIV/HCV co-infected patients, particularly African Americans.
- Controlled HIV replication, not liver disease severity, is a key risk factor for reduced bone mineral density (BMD).
- These findings highlight the need for bone health monitoring in HIV/HCV co-infected individuals.
Background & Aims:
To evaluate the prevalence and risk factors for low bone mineral density (BMD) in persons co-infected with HIV and Hepatitis C.
Methods:
HIV/HCV co-infected study participants (n=179) were recruited into a prospective cohort and underwent dual-energy X-ray absorptiometry (DXA) within 1 year of a liver biopsy. Fibrosis staging was evaluated according to the METAVIR system. Osteoporosis was defined as a T-score ≤-2.5. Z-scores at the total hip, femoral neck, and lumbar spine were used as the primary outcome variables to assess the association between degree of liver disease, HIV-related variables, and BMD.
Results:
The population was 65% male, 85% Black with mean age 50.3 years. The prevalence of osteoporosis either at the total hip, femoral neck, or lumbar spine was 28%, with 5% having osteoporosis of the total hip, 6% at the femoral neck, 25% at the spine. The mean Z-scores (standard deviation) were -0.42 (1.01) at the total hip, -0.16 (1.05) at the femoral neck, and -0.82 (1.55) at the lumbar spine. In multivariable models, controlled HIV replication (HIV RNA <400 copies/ml vs. ≥400 copies/ml) was associated with lower Z-scores (mean ± standard error) at the total hip (-0.44 ± 0.17, p = 0.01), femoral neck (-0.59 ± 0.18, p = 0.001), and the spine (-0.98 ± 0.27, p = 0.0005). There was no association between degree of liver fibrosis and Z-score.
Conclusions:
Osteoporosis was very common in this population of predominately African-American HIV/HCV co-infected patients, particularly at the spine. Lower BMD was associated with controlled HIV replication, but not liver disease severity.
Related Concept Videos
Retrovirus Life Cycles
Hepatitis
Cytomegalovirus Disease
Inhibitors of Viral Protein Synthesis
Cryptococcal Meningitis
Sexually Transmitted Infections

